PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees24
Employees24
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees24
Employees24
PDSB Key Statistics
Market cap60.62M
Market cap60.62M
Price-Earnings ratio-1.42
Price-Earnings ratio-1.42
Dividend yield—
Dividend yield—
Average volume715.38K
Average volume715.38K
High today$1.37
High today$1.37
Low today$1.28
Low today$1.28
Open price$1.32
Open price$1.32
Volume749.24K
Volume749.24K
52 Week high$4.29
52 Week high$4.29
52 Week low$0.8505
52 Week low$0.8505
PDSB News
TipRanks 23h
PDS Biotechnology Reports Promising Phase 2 Trial ResultsElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 1d
PDS Biotechnology announces data from its VERSATILE-002 Phase 2 trialPDS Biotechnology (PDSB) announced final topline survival data from its VERSATILE-002 Phase 2 clinical trial. VERSATILE-002 evaluated PDS0101 + Keytruda in pati...
People also own
Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.